ABUS
Arbutus Biopharma Corporation
$4.27
+$0.16(+3.89%)
48
Overall
40
Value
50
Tech
55
Quality
Market Cap
$822.39M
Volume
446.47K
52W Range
$2.71 - $5.10
Target Price
$5.25
EPS Estimates Overview
| Current Quarter | $NA | Next Quarter | $NA |
| Current Year | $-0.18 | Next Year | $-0.17 |
| QoQ Growth | NaN% | YoY Growth | +5.6% |
| 3Y EPS CAGR | +22.9% | Target Price | $5.25 |
| Consensus | Buy | Upside | +23.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABUS | $4.27 | +3.9% | 446.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arbutus Biopharma Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW